Effect of Daily Oral Administration of Salmon Milt Peptides on Postprandial Blood Glucose Level: Placebo-controlled Double Blind Cross Over Clinical Trial - Effect of Daily Oral Administration of Salmon Milt Peptides on Postprandial Blood Glucose Level

Hokkaido Information University0 个研究点目标入组 18 人开始时间: 2016年11月24日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Subjects who are under treatment and medication for diabetes and dyslipidemia. 2.Subjects whose HbA1c>=6.5% 3.Subjects whose FBG>=126 mg/dl. 4.Subjects whose BFP>=40% 5.Subjects with serious disease and infection. 6.Subjects with clinical history of gastrointestinal surgery. 7.Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. 8.Subjects with serious anemia. 9.Subjects with frequent complaints of post-menopausal symptoms. 10.Subjects with a history of allergy to medicine and food, especially salmon. 11.Subjects regularly take medicine, functional foods and/or supplements which would affect glucose metabolism. 12.Subjects regularly take medicine, functional foods and/or supplements which would affect lipid metabolism. 13.Subjects who are heavy smokers and alcohol addicts, or subjects with irregular lifestyle. 14.Subjects who donated either 400 ml whole blood within 12 weeks (men) /16 weeks (women) or 200 ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 15.Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. 16.Subjects who participate in other clinical trials within the last 4 weeks prior to the current clinical trial. 17.Subjects who are not eligible due to physician's judgment.

发起方